Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Hydroxychloroquine and Itraconazole as Therapy for Men With Androgen Normalised Prostate Cancer

NCT03513211 is registered in ClinicalTrials.gov with St Vincent's Hospital, Sydney as lead sponsor.

NCT NCT03513211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03513211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Hydroxychloroquine and Itraconazole as Therapy for Men With Androgen Normalised Prostate Cancer
Lead sponsor
St Vincent's Hospital, Sydney
Phase
Phase 1/2
Overall status
Completed
Start date
August 23, 2018
Completion date
October 30, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer